Pick the business you’re actually starting
Two very different businesses get called a “peptide business.” The first sells vials labeled research-use-only and hopes nobody asks questions. The second runs a clinical program: patients complete a medical intake, a licensed provider reviews and prescribes, and a licensed pharmacy compounds and ships. The first is faster to start — and routinely ends in frozen processor funds, ad bans, and FDA warning letters. The second is the one still standing in three years.
Learn who is allowed to do what
The value chain has three roles, and the law is picky about who plays which: the operator (you) owns the brand and storefront; licensed providers own every clinical decision; licensed pharmacies own dispensing. Corporate-practice-of-medicine rules are why real programs run an MSO structure — the operator manages the business layer without ever employing the medicine.
| Role | License required | What they control |
|---|---|---|
| Operator (you) | None | Brand, storefront, pricing, audience |
| Providers | State medical license | Every prescribing decision |
| Pharmacy | State license · 503A/503B | Compounding, dispensing, shipping |
Stand up the clinical workflow
The pipeline is intake → provider review → prescription → refill. Each state sets its own rules for async visits, and every state a customer lives in needs a licensed provider to route to. This is the layer that takes quarters to build and days to rent.
- Async-visit rules mapped for every state you’ll serve
- Provider network licensed in those states, with peptide-specific protocols
- Adverse-event escalation path documented before launch
- Refill cadence tied to provider re-review, not just billing cycles
Source from licensed pharmacies only
503A pharmacies compound per-patient prescriptions; 503B outsourcing facilities produce in batches under stricter federal oversight. Real programs use both — what they never use is a “supplier” with no prescription requirement.
Solve payments and LegitScript early
Card networks classify peptide telehealth as high-risk. LegitScript certification is what keeps Stripe processing and Meta ads on — reviews take 4–10 weeks, so it’s the long pole in every launch plan. Start it first, not last.
Featured readWhat You Can Sell Before LegitScript Approves YouComing soonBuild the storefront and intake funnel
The storefront is the one layer that is genuinely yours — brand, offer, content, and the intake funnel that converts attention into patients. Keep claims inside the compliance lines and design the intake to feel like your brand from first click to shipped box.
Run the launch math
| Line item | Building it yourself | On infrastructure (FUSE) |
|---|---|---|
| Provider network | 6–12 months of contracting | Included, all 50 states |
| Platform build | $150K+ engineering | Included |
| LegitScript | You run the process | Run as part of launch |
| Pharmacy contracts | Months of BD | Pre-integrated 503A/503B |
| Time to first Rx | 9–18 months | Days |
“We spent eight months trying to sign a compounding pharmacy on our own. On FUSE it was a dropdown.”
Launch this on FUSE
The whole stack in this guide, rented — live in 3–5 business days.
Frequently asked questions
Is selling peptides legal in 2026?
Through the prescription route, yes: licensed clinicians evaluate each patient and regulated 503A/503B compounding pharmacies fill the orders. Selling research-use-only vials to human consumers is the enforcement pattern to avoid — it's the top target for both the FDA and the card networks.
Do I need a medical license?
No — not to own the brand. Licensed providers make every clinical decision and licensed pharmacies dispense; the operator owns the storefront, audience, and pricing, structured so you never touch clinical decisions.
How much does it cost to start?
On existing infrastructure like FUSE, typically $2–15K all-in (largely LegitScript and launch marketing) and days-to-weeks to first prescription. Building your own stack runs $250K+ and 9–18 months.
Can I run this as a solo founder?
Yes. The clinical, pharmacy, payments, and compliance layers are rented — what remains (brand, content, audience) is a one-person job at launch.
Which peptides can my program offer?
Eligibility is set by FDA compounding rules and varies by state; the independent clinician makes the final call per patient. The maintained legality guide tracks Category 1 vs Category 2 with dates.
- FDA — Human Drug Compounding (503A / 503B) — fda.gov
- LegitScript — Healthcare Merchant Certification standards — legitscript.com
- Telehealth.HHS.gov — Getting started with telehealth — telehealth.hhs.gov
